Abstract
Objective
To explore the pregnancy outcomes of embryo transfer with D2 or D3 embryos in patients with poor ovarian response.
Methods
The pregnancy outcomes of 620 patients who had poor ovarian response and underwent the first in vitro fertilization-embryo transfer (IVF-ET) were retrospectively analyzed. Of the 620 cycles, all available fresh D2 embryos were used in 365 cycles (day 2 embryo transfer) and all available fresh D3 embryos were used in 255 cycles (day 3 embryo transfer) without superfluous embryos for freezing.
Results
There was a significant difference in clinical pregnancy rate between day 2 (32.73 %) and day 3 (50.83 %) embryo transfer in younger than 35-year-old patients, but no significant differences in implantation rate, live birth rate and spontaneous abortion rate (P > 0.05). There were similar pregnancy outcomes between day 2 and 3 embryo transfer in 35-year and older patients.
Conclusion
D3 embryo transfer may have better pregnancy outcomes in younger than 35-year-old patients with poor ovarian response.
Similar content being viewed by others
References
Shen S, Rosen MP, Dobson AT, Fujimoto VY, McCulloch CE, Cedars MI. Day 2 transfer improves pregnancy outcome in in vitro fertilization cycles with few available embryos. Fertil Steril. 2006;86:44–50.
Bahceci M, Ulug U, Ciray HN, Akman MA, Erden HF. Efficiency of changing the embryo transfer time from day 3 to day 2 among women with poor ovarian response: a prospective randomized trial. Fertil Steril. 2006;86:81–5.
Frankfurter D, Keefe DL, Timarchi JB. Day 2 embryo transfer improves IVF-ET outcome in the poor responder. Fertil Steril. 2003;80 Suppl 3:S61.
Ravhon A, Weissman A, Fleischfarb Z, et al. Day 3 versus day 2 embryo transfer in daily clinical practice: is it worth or worse to expand the culture time? Fertil Steril. 2006;86 Suppl 2:S246.
Frandstrom M, Akerlof E, Sjoblom P, Hillensjo T. Serum levels of Luteinizing and follicle stimulating hormones in nomal and poor responding patients undergoing ovarian stimulation with urofollitropin after pituitary down regulaIio. Gy Endocrinol. 1997;11:25–8.
Raga F, Bonilla Musoles F, Casan EM, Bonilla F. Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradio: improved reproductive outcome. Hum Reprod. 1999;14:1431–4.
Rombauts L, Suikkari A, Madachlan V, Trounson AO, Healy DL. Recruitment of follicles by recombinant human follicle stimulating hormone commencing in the luteal phase of the ovarian cycle. Fertit Steril. 1998;69:665669.
Sallam HN, Ezzeldin F, Agameya AF, Rahman AF, El-Garem Y. Defining poor responders in assisted reproduction. Int J Fertil Womens Med. 2005;50:115–20.
Lindheim SR, Barad DH, Witt B, Ditkoff E, Sauer MV. Short term gonadotrpin suppression with oral contraceptive benefits poor respond prior to controlled ovarian hyperstimulalion. J Assist Reprod Genet. 1996;9:745–7.
Brzyski RG, Muasher SJ, Droeseh K, Simonetti S, Jones GS, Rosenwaks Z. Follicular atresia associated with concurrent initiation of gonadotropin releasing hormone agonist and follicle. Fertil Steril. 1988;50:917–21.
Brirtsden PR. A textbook of in vitro fertilization and assisted reproduction. New York: Parthenon Publishing Group lnc 1999:96.
Castelo Branco A, Achour-Frydman N, Kadoch J, Fanchin R, Tachdjian G, Frydman R. In vitro fertilization and embryo transfer in seminature cycles for patients with ovarian aging. Fertil Steril. 2005;84:875–80.
Almeida PA, Bolton VN. Cytogenetic analysis of human preimplantation embryos following developmental arrest in vitro. Reprod Fertil Dev. 1998;10:505–13.
Laverge H, De Sutter P, Van der Elst J, et al. A prospective, randomized study comparing day 2 versus day 3 embryo transfer in human IVF. Hum Reprod. 2001;16:476–80.
Ashrafi M, Kiani K, Mirzaagha E, et al. The Pregnancy Outcomes of Day 2 versus Day 3 Embryo Transfer: A Cross-Sectional Study. Iranian Journal of Fertility & Sterility. 2007;1:47–54.
Shahine LK, Milki AA, Westphal LM, Baker VL, Behr B, Lathi RB. Day 2 versus day 3 embryo transfer in poor responders: a prospective randomized trial. Fertil Steril. 2011;95:330–2.
Acknowledgments
This study was supported by the Innovation Talent Fund for Healthy Science and Technology of Henan Province and the Youth Fund from the First Affiliated Hospital of Zhengzhou University.
Author information
Authors and Affiliations
Corresponding author
Additional information
Capsule
This study suggests that day 3 embryo transfer may have better pregnancy outcomes in younger than 35-year-old patients with poor ovarian response.
Rights and permissions
About this article
Cite this article
Xin, Zm., Xu, B., Jin, Hx. et al. Day 3 embryo transfer may have better pregnancy outcomes in younger than 35-year-old patients with poor ovarian response. J Assist Reprod Genet 29, 1077–1081 (2012). https://doi.org/10.1007/s10815-012-9830-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-012-9830-y